公司資料
Q BioMed 股價、新聞與催化劑
- 股票代碼:
- QBIO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for QBIO.
公司概覽
業務概覽
Q BioMed is a biotechnology company historically focused on rare disease, diagnostics, and therapeutic development. Its story has long been tied to a narrow set of assets and the challenge of building durable value from a micro-cap base.
所在地與產業分類
Q BioMed is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotech and rare-disease development.
商業模式特徵
The company depends on licensing, development progress, and capital discipline. Investors historically watched whether it could convert narrow assets into a sustainable business.
生技產業定位
Q BioMed occupies a historical micro-cap rare-disease niche within biotech. Its stock profile has always been shaped by capital structure and program-level optionality.
未來催化劑
- Q BioMed is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update. The market no longer treats it like a live growth name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。